CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Extracorporeal membrane oxygenationWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug233 Asynchronies detection Wiki 1.00

Correlated MeSH Terms (4)


Name (Synonyms) Correlation
D013577 Syndrome NIH 0.11
D055371 Acute Lung Injury NIH 0.10
D012127 Respiratory Distress Syndrome, Newborn NIH 0.10
D012128 Respiratory Distress Syndrome, Adult NIH 0.09

Correlated HPO Terms (0)


Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials


1 Outcome of COVID-19 Patients After Extracorporeal Membrane Oxygenation for Acute Respiratory Distress Syndrome: A Multicenter European Study

This study aims to investigate outcomes and predictors of outcome after extracorporeal membrane oxygenation (ECMO) therapy for severe acute respiratory syndrome (ARDS) in COVID-19 patients.

NCT04383678 COVID-19 Extracorporeal Membrane Oxygenation Complication Acute Respiratory Distress Syndrome Device: Extracorporeal membrane oxygenation
MeSH:Respiratory Distress Syndrome, Newborn Respiratory Distress Syndrome, Adult Acute Lung Injury Syndrome

Primary Outcomes

Measure: In-hospital mortality

Time: During index hospital stay follow-up until 1 year after ECMO initiation

Secondary Outcomes

Measure: Death on ECMO

Time: During index hospital stay follow-up until 1 year after ECMO initiation

Measure: Stroke

Time: During index hospital stay follow-up until 1 year after ECMO initiation

Measure: Blood stream infection

Time: During index hospital stay follow-up until 1 year after ECMO initiation

Measure: Lung complications requiring surgical treatment

Time: During index hospital stay follow-up until 1 year after ECMO initiation

Measure: Blood transfusion

Time: During index hospital stay follow-up until 1 year after ECMO initiation

Measure: Acute kidney injury

Time: During index hospital stay follow-up until 1 year after ECMO initiation

Measure: Duration of mechanical ventilation

Time: During index hospital stay follow-up until 1 year after ECMO initiation

Measure: Deep vein thrombosis

Time: During index hospital stay follow-up until 1 year after ECMO initiation

Measure: Pulmonary embolism

Time: During index hospital stay follow-up until 1 year after ECMO initiation

Measure: Length of ICU stay

Time: During index hospital stay follow-up until 1 year after ECMO initiation

Measure: Length of hospital stay

Time: During index hospital stay follow-up until 1 year after ECMO initiation

Measure: Death after hospital discharge

Time: During index hospital stay follow-up until 1 year after ECMO initiation


No related HPO nodes (Using clinical trials)